Design Therapeutics Balance Sheet (2020-2026) | DSGN

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
370.84M357.66M298.57M287.31M119.65M42.52M26.50M28.81M27.20M27.94M21.20M29.40M45.70M30.33M22.56M13.67M19.70M15.09M16.86M12.77M
Short-term Investments (Quarter)
32.00M0.10M85.50M83.91M239.72M301.72M303.89M286.58M275.89M263.00M260.60M241.29M215.32M223.75M222.91M216.01M196.57M190.88M202.99M210.05M
Cash & Current Investments (Quarter)
402.84M357.77M384.06M371.22M359.38M344.23M330.39M315.39M303.09M290.94M281.80M270.69M261.02M254.07M245.48M229.67M216.28M205.97M219.84M222.82M
Prepaid Assets (Quarter)
1.86M1.57M1.37M2.65M2.35M3.51M3.62M3.55M2.96M2.40M1.35M1.52M2.43M3.17M1.30M3.97M3.52M3.06M3.94M4.23M
Current Assets (Quarter)
404.88M395.29M385.44M373.87M361.72M348.49M335.12M318.94M306.05M294.54M284.58M273.89M264.84M257.24M248.04M233.64M219.79M209.03M223.78M227.05M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.27M1.32M1.51M1.45M1.80M1.84M1.95M1.91M1.86M1.78M1.69M1.72M1.73M1.56M1.41M1.38M1.26M1.10M0.98M0.82M
Other Non-Current Assets (Quarter)
0.47M0.47M0.46M0.45M0.44M0.44M0.43M0.43M0.43M0.43M0.43M0.43M
Non-Current Assets (Quarter)
0.27M5.06M5.12M4.93M6.21M6.08M6.02M5.80M5.58M5.33M5.06M4.91M4.74M4.39M4.05M3.83M3.09M2.74M2.42M3.39M
Assets (Quarter)
405.15M400.35M390.56M378.80M367.93M354.57M341.14M324.74M311.63M299.87M289.64M278.79M269.58M261.63M252.09M237.47M222.89M211.77M226.20M230.44M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.58M2.22M1.62M1.90M2.07M7.79M7.75M6.30M10.21M2.21M1.94M5.72M5.10M5.96M2.19M5.06M1.01M1.91M10.74M2.28M
Payables (Quarter)
1.58M2.22M1.62M1.90M2.07M7.79M7.75M6.30M10.21M2.21M1.94M5.72M5.10M5.96M2.19M5.06M1.01M1.91M10.74M2.28M
Accumulated Expenses (Quarter)
0.94M
Other Accumulated Expenses (Quarter)
0.24M
Total Current Liabilities (Quarter)
3.40M5.50M5.28M5.48M7.39M10.41M10.78M9.05M12.13M12.39M9.62M7.09M6.39M7.43M8.46M8.24M8.75M11.17M13.05M10.19M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
3.27M3.14M3.01M3.38M3.22M3.05M2.88M2.70M2.52M2.33M2.14M1.95M1.74M1.53M1.32M1.10M0.88M0.65M2.20M
Other Non-Current Liabilities (Quarter)
0.14M0.01M
Total Non-Current Liabilities (Quarter)
3.40M8.78M
Total Liabilities (Quarter)
3.54M8.79M8.43M8.49M10.77M13.63M13.83M11.93M14.84M14.91M11.96M9.24M8.34M9.18M10.00M9.56M9.85M12.05M13.70M12.39M
Shareholder's Equity
Common Equity (Quarter)
401.60M391.56M382.13M370.31M357.16M340.94M327.31M312.82M296.80M284.96M277.69M269.56M261.24M252.45M242.10M227.92M213.04M199.72M212.50M218.05M
Shareholder's Equity (Quarter)
401.60M391.56M382.13M370.31M357.16M340.94M327.31M312.82M296.80M284.96M277.69M269.56M261.24M252.45M242.10M227.92M213.04M199.72M212.50M218.05M
Liabilities and Shareholders Equity (Quarter)
405.15M400.35M390.56M378.80M367.93M354.57M341.14M324.74M311.63M299.87M289.64M278.79M269.58M261.63M252.09M237.47M222.89M211.77M226.20M230.44M
Retained Earnings (Quarter)
-0.01M-0.00M-0.24M-1.32M-75.72M-3.86M-110.76M-1.98M-150.00M-165.80M0.06M-188.73M-200.52M-213.60M-227.21M-244.93M-264.01M0.36M0.40M-314.60M
Shares Outstanding (Quarter)
55.11M55.22M55.44M55.62M55.72M55.84M55.90M55.92M55.98M56.00M56.47M56.49M56.62M56.62M56.75M56.77M56.95M56.96M60.40M62.44M